Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Scadden currently holds 17,603 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Scadden has been a net buyer of AGIO stock. They have purchased $115.7K and sold $89.0K worth of shares.
David Scadden's most recent insider trade was on Nov 12, 2025, when they sold 200 shares at $43.84 per share.
David Scadden serves as Executive at AGIOS PHARMACEUTICALS, INC. (AGIO). They have executed 25 insider transactions totaling $204.7K over their tenure at the company.
David Scadden holds the position of Executive at AGIOS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David Scadden has shown a buying trading pattern, with $115.7K in total purchases and $89.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Scadden was on Jun 25, 2018, when they purchased $99.0K worth of MGTA shares. This transaction involved 6,600 shares at $15.00 per share.
David Scadden currently owns 17,603 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Scadden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Scadden has 25 Form 4 filings on record as an insider at AGIOS PHARMACEUTICALS, INC..
Set alerts for David Scadden and 40,000+ other insiders.